Angela Rago

900 total citations
29 papers, 334 citations indexed

About

Angela Rago is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Angela Rago has authored 29 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 17 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Angela Rago's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Angela Rago is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Angela Rago collaborates with scholars based in Italy, United States and Malaysia. Angela Rago's co-authors include Giuseppe Cimino, Massimo Breccia, Roberto Latagliata, Alessandro Andriani, Maria Gabriella Mazzucconi, Cristina Santoro, Michele Cedrone, Marco Montanaro, Nicoletta Villivà and Sergio Mecarocci and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Angela Rago

27 papers receiving 331 citations

Peers

Angela Rago
Angela Rago
Citations per year, relative to Angela Rago Angela Rago (= 1×) peers Andrea Duminuco

Countries citing papers authored by Angela Rago

Since Specialization
Citations

This map shows the geographic impact of Angela Rago's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Rago with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Rago more than expected).

Fields of papers citing papers by Angela Rago

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Rago. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Rago. The network helps show where Angela Rago may publish in the future.

Co-authorship network of co-authors of Angela Rago

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Rago. A scholar is included among the top collaborators of Angela Rago based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Rago. Angela Rago is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zullo, Angelo, Vincenzo De Francesco, Luigi Gatta, et al.. (2023). Small bowel lesions in patients with iron deficiency anaemia without overt bleeding: a multicentre study. Annals of Hematology. 103(1). 1–4. 1 indexed citations
3.
Francesco, Vincenzo De, Raffaele Manta, Riccardo Marmo, et al.. (2022). Efficacy of Helicobater pylori eradication in patients with diffuse large B‐cell lymphoma of the stomach: A systematic review. European Journal Of Haematology. 109(6). 643–647. 5 indexed citations
4.
Rago, Angela, et al.. (2022). Immunotactoid glomerulopathy and chronic lymphocytic leukemia: The need for a multidisciplinary approach. SHILAP Revista de lepidopterología. 4(1). 266–268. 1 indexed citations
5.
Rago, Angela, Ombretta Annibali, Francesca Fazio, et al.. (2022). Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case–control study. European Journal Of Haematology. 109(3). 250–256. 2 indexed citations
6.
Rago, Angela, et al.. (2021). Pulmonary arterial hypertension in a patient with multiple myeloma during carfilzomib treatment: in search of better management. Tumori Journal. 107(6). NP37–NP40. 5 indexed citations
7.
Mazzucconi, Maria Gabriella, Roberto Latagliata, Massimo Breccia, et al.. (2020). Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the “Ph1‐negative Myeloproliferative Neoplasms Latium Group”. European Journal Of Haematology. 105(3). 335–343. 10 indexed citations
8.
Nicolai, Emanuele, Mara Riminucci, Candida Vitale, et al.. (2020). Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy. Cancers. 12(7). 1773–1773. 6 indexed citations
9.
Capuano, Cristina, Chiara Pighi, Giuseppe Cimino, et al.. (2015). Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells. Cancer Research. 75(19). 4097–4108. 41 indexed citations
10.
Latagliata, Roberto, Ambra Di Veroli, Pasquale Niscola, et al.. (2015). Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase. European Journal Of Haematology. 96(6). 643–649. 16 indexed citations
11.
Cimino, Giuseppe, Jan Maciej Zaucha, S. Cirillo, et al.. (2014). The Complementary Prognostic Role of Baseline and Interim PET in Predicting Treatment Outcome in Advanced-Stage Hodgkin Lymphoma. Blood. 124(21). 4405–4405. 4 indexed citations
12.
Marchesi, Francesco, Maria Laura Dessanti, Sergio Mecarocci, et al.. (2013). A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment. Journal of Geriatric Oncology. 4(3). 242–248. 30 indexed citations
13.
Pessina, G, Sergio Mecarocci, Angela Rago, et al.. (2013). A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms. Annals of Hematology. 93(4). 609–616. 4 indexed citations
14.
Latagliata, Roberto, Pasquale Niscola, Fabrizio Ciccone, et al.. (2013). Deferasirox In The Treatment Of Iron Overload During Myeloproliferative Neoplasms (MPN). Blood. 122(21). 1594–1594. 1 indexed citations
15.
Rago, Angela, Sara Grammatico, Tommaso Zà, et al.. (2012). Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form. Cancer. 118(22). 5544–5549. 9 indexed citations
16.
Miscusi, Massimo, et al.. (2012). Subacute combined degeneration without nutritional anemia. Journal of Clinical Neuroscience. 19(12). 1744–1745. 7 indexed citations
17.
Elia, Loredana, Sara Grammatico, Francesca Paoloni, et al.. (2011). Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene. American Journal of Hematology. 86(12). 993–997. 5 indexed citations
18.
Santoro, Cristina, Angela Rago, Francesca Biondo, et al.. (2010). Prevalence of allo‐immunization anti‐HLA and anti‐integrin αIIbβ3 in Glanzmann Thromboasthenia patients. Haemophilia. 16(5). 805–812. 38 indexed citations
19.
Famà, Angelo, Angela Rago, Chiara Marzano, et al.. (2010). [Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].. PubMed. 161(2). 169–71. 1 indexed citations
20.
Latagliata, Roberto, Angela Rago, Antonio Spadea, et al.. (2009). Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results. International Journal of Hematology. 90(4). 486–491. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026